Summary
The variability of plasma amiodarone levels in 51 patients receiving chronic oral therapy over 4–53 (median 19) months was examined; 3–14 (median 5) plasma samples were obtained. After a loading dose, most patients received either 200mg or 400mg a day. Mean plasma amiodarone concentration was 1.2±0.6mg/l and mean plasma desethylamiodarone concentration, was 1.2±0.5mg/l. No relationship was seen between height and weight and plasma concentrations. Dose was a significant predictor of plasma level (p<0.01) although it was a poor predictor of steady state amiodarone concentration.
Similar content being viewed by others
References
Haffajee CI, Love JC, Canada AT et al. Clinical pharmacokinetics and efficacy of aminodarone for refractory tachyarrhythmias.Circulation 1983;67:1347–1355.
Heger JJ, Prystowsky EN, Zipes DP. Relationships between amiodarone dosage, drug concentrations and adverse side effects.Am Heart J 1983;106:931–935.
Staubli M, Bircher J, Caleazzi RL, et al. Serum concentrations of amiodarone during long term therapy: Relation to dose efficacy and toxicity.Eur J Clin Pharm 1983;24:485–494.
Holt DW, Tucker GT, Jackson PR, et al. Amiodarone pharmacokinetics.Am Heart J 1983;106:840–847.
Andreasen F, Agerback H, Bjerregard P, et al. Pharmacokinetics of amiodarone after intravenous and oral administration.Eur J Clin Pharm 1981;19.:2–9.
Storey GCA, Holt DW. High performance liquid chromatographic measurement of amiodarone and its desethylmetabolite in plasma or serum at the concentrations attained following a single 400 mg dose.J Chromatogr 1982;245:377–380.
Schwartz JB, Keefe DL, Kirsten E, et al. Prolongation of verapamil elimination kinetics during chronic oral administration.Am Heart J 1982;104:198–203.
Bauer LA, Brown T, Gibaldi M, et al. Influence of long-term infusions on lidocaine kinetics.Clin Pharmacol Ther 1982; 31:433–439.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Robinson, K., Johnston, A., Walker, S. et al. Stability of plasma amiodarone levels during chronic oral therapy. Cardiovasc Drug Ther 4, 529–530 (1990). https://doi.org/10.1007/BF01857765
Issue Date:
DOI: https://doi.org/10.1007/BF01857765